Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Garry Gelerman"'
Autor:
Chaim Gilon, Moshe Bracha, Sharon Gazal, Olga Karpov, Ofer Ziv, Michel Afargan, Garry Gelerman, Pninit Litman
Publikováno v:
Journal of medicinal chemistry. 45(8)
Somatostatin-14 (somatostatin) and its clinically available analogues octreotide, lanreotide, and vapreotide are potent inhibitors of growth hormone, insulin, and glucagon release. Recently, a novel backbone cyclic somatostatin analogue c(GABA-Phe-Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f6b852fd2a964da6a2ac8b9978bed56
https://pubmed.ncbi.nlm.nih.gov/11931620
https://pubmed.ncbi.nlm.nih.gov/11931620
Autor:
Offer Ziv, Michel Afargan, Rakefet Rosenfeld, David Stephensky, Dvira Shohat, Moshe Bracha, George Liapakis, Amnon Hoffman, Olga Karpov, Garry Gelerman, Amnon Wolf, Eva Tiensuu Janson, Kjell Öberg, Chaim Gilon
Publikováno v:
Endocrinology. 142(1)
Somatostatin, also known as somatotropin release-inhibiting factor (SRIF), is a natural cyclic peptide inhibitor of pituitary, pancreatic, and gastrointestinal secretion. Its long-acting analogs are in clinical use for treatment of various endocrine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8266135168b651446957098155b047c
https://pubmed.ncbi.nlm.nih.gov/11145612
https://pubmed.ncbi.nlm.nih.gov/11145612
Autor:
Offer Ziv, Michel Afargan, Rakefet Rosenfeld, Eva Tiensuu Janson, Olga Karpov, Garry Gelerman, Kjell Öberg, Moshe Bracha
Publikováno v:
Regulatory Peptides. 94:74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cddd168caa00397477194232772d4932
https://doi.org/10.1016/s0167-0115(00)80149-4
https://doi.org/10.1016/s0167-0115(00)80149-4